Let's be honest about something. If you don't live in the AI world, keeping up with it is exhausting.

Anthropic ships a new model, then a feature, then renames the thing you just learned. Every week there's a launch, a benchmark, a thread explaining why this one changes everything. And if you're in medical writing, or in Pharma marketing, or Medical affairs, or anywhere in medical or marketing communications, your job is the science, the protocol, the accurate representation, fair balance, and compliance of communicating the science and the brand to HCPs and Patents. It’s definitely not to keep a running tab on on which AI feature shipped this week, who is on the leaderboard of beating benchmarks today, or what an overoptimistic AI CEO said on the latest Lex Friedman podcast.

So that's what I want to do here. Make this article your one stop shop for the most important updates on the most useful AI features that are useful in your day to day.

Claude has grown from "a chatbot you talk to" into a broader ecosystem: a family of models, plus Connectors, Research, Projects, Skills, Claude Code, Artifacts, Design, Cowork, and an integration standard called MCP. For each capability, two questions: what does this actually do for someone in medical affairs or commercial, and where do you still keep your hand firmly on the wheel?

I think this article is necessary because these features are genuinely useful. But they're also not magic. The places where they fall short are often the places life sciences cannot afford to be casual about. Both things are true at once.

First, the Models: Opus, Sonnet, and Haiku

"Claude" isn't one model. It's a family, and the three main tiers trade speed against horsepower. Opus is the heavyweight, built for difficult reasoning and complex, multi-step work. Sonnet is the balanced workhorse: fast enough for daily use, still highly capable. Haiku is the lightweight option, optimized for speed and scale when deep reasoning matters less.

In scientific communications the distinction is practical. Reach for Haiku on high-volume, low-judgment tasks: tagging abstracts by therapy area, reformatting references, a first pass at deduplicating a literature search. Use Sonnet for the bulk of real work: drafting a plain-language summary, restructuring a slide narrative, answering "what does this paper actually say." Save Opus for the few tasks where stakes or complexity justify it: synthesizing a dozen papers into a coherent evidence story, untangling a contradictory dataset, anything heading toward a regulator, peer reviewer, or physician.

The challenge: A stronger model is more capable, not infallible. Bigger models produce polished, authoritative-sounding answers, and confidence is exactly what makes an error harder to spot. The primary challenge is overconfidence, not just hallucination. Capability is not correctness, and no model tier removes the need for someone who understands the science to read the work carefully.

Connectors: Plugging Claude Into Your Sources

On its own, a model only knows what it was trained on, with a cutoff date. Connectors are the bridge, letting Claude reach into specific, trusted sources rather than relying on memory. Claude for Life Sciences leans heavily on this, integrating with systems researchers already use, including Benchling, PubMed, 10x Genomics, BioRender, Synapse.org, and Wiley's Scholar Gateway. The goal is simple: bring the data into the workflow instead of forcing people to copy-paste between fifteen tabs.

The challenge: Connectors solve access, not completeness. Claude may retrieve a perfectly good paper and still lean too heavily on it, miss an important counter-study, or summarize the evidence unevenly. The challenge is retrieval bias. Someone still has to ask: did the model find enough evidence, and did it represent that evidence fairly?

Research: From Retrieval to Synthesis

Rather than answering a single question, Research runs a deeper, multi-step investigation, searching across the open web and connected sources, following threads, and assembling a structured picture with references. For someone mapping an unfamiliar disease pathway or building the background for a publication strategy, this can replace hours of manual searching.

The challenge: The temptation is to over-trust the output because it looks complete. The structure is polished, the references listed. But synthesis is interpretation. A report can over-weight one source, miss a counter-finding, or flatten a nuanced result into a cleaner story than the evidence supports. The challenge is not really whether Claude found the right information. It's whether it assembled the right picture from it. Think of this as getting assistance with a literature review, not a replacement for scientific judgment.

Projects and Long Context: Holding the Background in One Place

Most AI chats start from zero every time. Projects fix that, giving you a persistent workspace that holds context across a long-running program. Paired with Claude's long context window, you can keep approved content, product labels, publications, and internal guidance close at hand without re-explaining the background every session.

The challenge: A Project preserves context, but it doesn't inherently track how that context evolves. A label gets updated. A publication is superseded. A safety signal emerges. The workspace still remembers the old world, but it doesn't automatically understand that the old world is no longer the approved one. In life sciences, context is a moving target, and someone still has to make sure the work reflects the latest approved truth.

Skills: Teaching Claude Your Way of Doing Things

A Skill is a reusable set of instructions that teaches Claude how to perform a recurring task the way your team wants it done. Instead of re-explaining your house style or formatting rules every time, you define them once and reuse them: a referencing format, a QC checklist, a way of structuring a publication summary. For teams producing the same deliverables repeatedly, consistency starts to feel automatic.

The challenge: Skills make processes repeatable, not correct. An outdated reference style or a superseded SOP will be applied just as faithfully as a good one. A small mistake becomes a systematic one. Skills still need an owner who keeps them current.

Claude Code: Turning Analysis Into Something You Can Run

Early generative AI could describe a workflow beautifully and participate in it not at all. It was the consultant who writes a great deck and then leaves. Claude Code changes that, generating code, executing workflows, and interacting with development tools under user control. A computational biologist can build an analysis script; teams can automate work that used to consume hours.

The challenge: Automation at scale. Automation faithfully repeats whatever logic it was given. A flawed assumption or incorrect method can be executed hundreds of times just as efficiently as a correct one. Before generated code informs a regulatory or clinical decision, someone has to confirm the method is sound, the assumptions hold, and the results reproduce. Speed at the drafting stage can create a false sense of done at the stage that actually matters.

Artifacts and Design: From Output to Document

Artifacts take Claude's answer out of the chat bubble and turn it into an actual, editable document you revise alongside the conversation. Design extends the same idea into visual material, generating decks, layouts, and graphics from a plain-language description. For turning dense scientific material into a first draft, or a rough idea into a presentable slide, both remove real friction.

The challenge: A finished-looking artifact feels finished, and a clean slide lends authority to a figure no one re-checked. Polish is exactly when an unverified claim sails through. The formatting improves; the obligation to verify does not.

Cowork and MCP: Sharing It, Connecting It

Cowork moves Claude from a personal assistant to a shared workspace, so medical, regulatory, and commercial teams work from the same thread instead of three slightly different versions of the truth.

The challenge: Propagation is difficult to implement. Shared workspaces spread whatever is in them, accurate or not. One unverified figure quickly becomes everyone's figure.

MCP, the Model Context Protocol, is the universal adapter that lets new tools and data sources plug into the ecosystem without bespoke engineering.

The challenge: Governance. Every new connection is another question about access, permissions, and data handling.

What all of this adds up to

Step back from the individual features, and a deliberate pattern comes into focus. Stitched together, these capabilities look less like a chatbot and more like a nervous system for knowledge work. It's genuinely impressive. But here's what's conspicuously missing: every feature removes friction from creating content, yet none proves the content is true. Life sciences has never been short on information; we're drowning in it. The hard part is proving every claim is supported, current, and approved. That gap isn't a bug the next model release patches. It's structural. General-purpose AI is built to help you create; regulated industries have to govern what gets created.

This is exactly why I am building LogicFlo AI. A shameless plug, maybe, but when a problem keeps you up most nights, the pitch and the conviction are often difficult to separate. We don't replace the underlying model, and wouldn't want to. There's no point competing at the model layer unless you have Elon Musk levels of capital and compute lying around. The real work sits in the layers above it, the part that makes these tools usable in the regulated world rather than just for planning your weekend getaway: keeping claims tethered to approved sources, reflecting the latest approved truth, and preserving traceability to the final deliverable.

As these models grow more fluent, this matters more, not less. When AI output was visibly rough, everyone double-checked it; the danger now is the polish. The future here was never one system that knows everything, but a powerful engine with the right rails around it, evidence connected to output and experts in the loop by design.

Life sciences runs on evidence, and the next generation of AI will have to do more than retrieve it. Proving it is where the work, and the responsibility, still lives.